Yew Bio-Pharm Group, Inc. (YEWB)
Yew Bio-Pharm Group, Inc. operates in the Agricultural Farm Products industry of the Consumer Defensive sector, headquartered in El Monte, CA, US. The stock last traded at $0.00, down 80.00% on the session, giving a market capitalisation of $11,838. On trailing twelve-month figures it carries a trailing P/E of 0.01, a net margin of 5.4%. Its beta of -0.68 implies it has historically moved less than the broad market.
Yew Bio-Pharm Group, Inc. (YEWB) operates as a cultivator and purveyor of yew trees across both the People's Republic of China and the United States, utilizing its subsidiaries. A significant portion of its operations involves supplying raw yew materials, specifically branches and leaves, for the production of Traditional Chinese Medicine (TCM), particularly those containing the compound taxol. The company also processes and distributes these vital yew components for TCM applications. Beyond medicinal applications, Yew Bio-Pharm cultivates and markets various forms of yew trees, from young seedlings and mature specimens to ornamental potted miniatures. It also leverages yew tree timber for the creation and sale of furniture and handcrafted items. Its diverse product portfolio further includes a range of agricultural goods such as yew-based candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps. Additionally, it sells wood ear mushrooms. The group also extends its reach into the cosmetics market, engaging in their marketing and distribution. Established in 2007, the company maintains its headquarters in El Monte, California.
Yew Bio-Pharm Group, Inc. is most often compared with the following Consumer Defensive names: